Developing live biotherapeutics that target the core drivers of disease.

Developing better therapies through a deep understanding of human microbial ecology

As a next-generation live biotherapeutics developer, we combine clinical data, bioinformatics, and world-class microbial science to develop synergistic combinations of bacteria that target disease-specific mechanisms of action. By leveraging our proprietary Precision Symbiotics Platform™ and in-house GMP-manufacturing capabilities, we are rapidly expanding our product pipeline across multiple indications.